Saturday review: Opiant Pharmaceuticals, Johnson Matthey and HSBC
Saturday, 30 April 2022, 10:20 am
There were plenty of bits and pieces going on yesterday afternoon that little old Betaville wasn't able to get on top of as I was rather busy, so I thought I would chew over them today in the Saturday review.
One story that was brought to my attention was the bizarre goings on at Opiant Pharmaceuticals, a US-listed firm that makes medicines for the treatment of addictions...